intermittent treatment

DRUG2 trials

Sponsors

RWTH Aachen University, Shanghai Zhongshan Hospital

Conditions

Ankylosing SpondylitisSchizophreniaTherapeutic Agent Toxicity

Phase 4

Antipsychotic Induced Structural and Functional Brain Changes

TerminatedNCT02435095

RWTH Aachen UniversitySchizophrenia

Start: 2015-05-31End: 2020-08-31Updated: 2020-11-25

Unknown Phase

A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

Shanghai Zhongshan HospitalAnkylosing Spondylitis, Therapeutic Agent Toxicity

Start: 2020-05-07End: 2022-06-30Target: 196Updated: 2020-05-27